A panel of international medical and scientific experts on garlic has concluded that there is ample evidence to warrant an official health claim recognizing the numerous benefits of garlic in the prevention of cardiovascular disease. The panel urged that a proposal for such a health claim should be submitted to the U.S. Food and Drug Administration (FDA) for its review and consideration.
This group of specialists recently met at a Cardiovascular Garlic Symposium to discuss the broad scientific evidence that garlic powder LI 111 cannot only prevent the most relevant causes of heart disease, but may even reverse them. This proprietary standardized garlic extract was scrutinized extensively by international research, resulting in 42 clinical trials focused on the prevention and reversal of cardiovascular disease.